SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Cheng-long Xie, Jia-Lin Pan, Wen-Wen Wang, Yu Zhang, Su-fang Zhang, Jing Gan, Zhen-Guo Liu, The association between the LRRK2 G2385R variant and the risk of Parkinson’s disease: a meta-analysis based on 23 case–control studies, Neurological Sciences, 2014,

    CrossRef

  2. 2
    Jiangping Cai, Yi Lin, Wanjin Chen, Qifang Lin, Bin Cai, Ning Wang, Weihong Zheng, Association between G2385R and R1628P polymorphism of LRRK2 gene and sporadic Parkinson’s disease in a Han-Chinese population in south-eastern China, Neurological Sciences, 2013, 34, 11, 2001

    CrossRef

  3. 3
    Chao Gao, Hao Pang, Xiao-Guang Luo, Yan Ren, Hong Shang, Zhi-Yi He, LRRK2 G2385R variant carriers of female Parkinson’s disease are more susceptible to motor fluctuation, Journal of Neurology, 2013, 260, 11, 2884

    CrossRef

  4. 4
    Qilin Ma, Xingkai An, Zhiming Li, Huanjing Zhang, Wenqing Huang, Liangliang Cai, Peng Hu, Qing Lin, Chi-Meng Tzeng, P268S in NOD2 associates with susceptibility to Parkinson’s disease in Chinese population, Behavioral and Brain Functions, 2013, 9, 1, 19

    CrossRef

  5. 5
    Ji Sun Kim, Jin Whan Cho, Hyeeun Shin, Won Yong Lee, Chang-Seok Ki, Ah Ra Cho, Hee-Tae Kim, A Korean Parkinson's disease family with the LRRK2 p.Tyr1699Cys mutation showing clinical heterogeneity, Movement Disorders, 2012, 27, 2
  6. 6
    Yishu Zhou, Xiaoguang Luo, Fengrui Li, Xiaofei Tian, Lanhui Zhu, Yichun Yang, Yan Ren, Hao Pang, Association of Parkinson’s disease with six single nucleotide polymorphisms located in four PARK genes in the northern Han Chinese population, Journal of Clinical Neuroscience, 2012, 19, 7, 1011

    CrossRef

  7. 7
    Jia Liu, Yongtao Zhou, Chaodong Wang, Tao Wang, Zheng Zheng, Piu Chan, Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease, Parkinsonism & Related Disorders, 2012, 18, 2, 140

    CrossRef

  8. 8
    Xi Wu, Ke-Fu Tang, Yang Li, Yu-Yu Xiong, Lu Shen, Zhi-Yun Wei, Ke-Jun Zhou, Jia-Min Niu, Xia Han, Lun Yang, Guo-Yin Feng, Lin He, Sheng-Ying Qin, Quantitative assessment of the effect of LRRK2 exonic variants on the risk of Parkinson’s disease: A meta-analysis, Parkinsonism & Related Disorders, 2012, 18, 6, 722

    CrossRef

  9. 9
    Xue-Li Chang, Xue-Ye Mao, Hui-Hua Li, Jin-Hong Zhang, Nan-Nan Li, Jean-Marc Burgunder, Rong Peng, Eng-King Tan, Association of GWAS loci with PD in China, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2011, 156, 3
  10. 10
    A. H. V. Schapira, Challenges to the development of disease-modifying therapies in Parkinson’s disease, European Journal of Neurology, 2011, 18,
  11. 11
    Naomi Seki, Yuji Takahashi, Hiroyuki Tomiyama, Ekaterina Rogaeva, Shigeo Murayama, Yoshikuni Mizuno, Nobutaka Hattori, Connie Marras, Anthony E Lang, Peter St George-Hyslop, Jun Goto, Shoji Tsuji, Comprehensive mutational analysis of LRRK2 reveals variants supporting association with autosomal dominant Parkinson's disease, Journal of Human Genetics, 2011, 56, 9, 671

    CrossRef

  12. 12
    Soraya Bardien, Suzanne Lesage, Alexis Brice, Jonathan Carr, Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson’s disease, Parkinsonism & Related Disorders, 2011, 17, 7, 501

    CrossRef

  13. 13
    Ling-yan Yao, Ji-feng Guo, Lei Wang, Ren-he Yu, Qi-ying Sun, Qian Pan, Kun Xia, Bei-sha Tang, Lu Shen, LRRK2 Pro755Leu variant in ethnic Chinese population with Parkinson's disease, Neuroscience Letters, 2011, 495, 1, 35

    CrossRef

  14. 14
    E. K. Tan, A. H. Schapira, New LRRK2 variants identified in Parkinson’s disease, European Journal of Neurology, 2011, 18, 3
  15. 15
    You-yong Tian, Cui-ju Tang, Jie Wu, Jun-shan Zhou, Parkinson’s disease in China, Neurological Sciences, 2011, 32, 1, 23

    CrossRef

  16. 16
    X.-Y. Mao, J.-M. Burgunder, Z.-J. Zhang, X.-K. An, J.-H. Zhang, Y. Yang, T. Li, Y.-C. Wang, X.-L. Chang, R. Peng, Association between GBA L444P mutation and sporadic Parkinson's disease from Mainland China, Neuroscience Letters, 2010, 469, 2, 256

    CrossRef

  17. 17
    Karen Nuytemans, Jessie Theuns, Marc Cruts, Christine Van Broeckhoven, Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update, Human Mutation, 2010, 31, 7
  18. 18
    Soraya Bardien, Angelica Marsberg, Rowena Keyser, Debbie Lombard, Suzanne Lesage, Alexis Brice, Jonathan Carr, LRRK2 G2019S mutation: frequency and haplotype data in South African Parkinson’s disease patients, Journal of Neural Transmission, 2010, 117, 7, 847

    CrossRef

  19. 19
    Yoshihiro Miyake, Yoshio Tsuboi, Midori Koyanagi, Takahiro Fujimoto, Senji Shirasawa, Chikako Kiyohara, Keiko Tanaka, Wakaba Fukushima, Satoshi Sasaki, Tatsuo Yamada, Tomoko Oeda, Takami Miki, Nobutoshi Kawamura, Nobutaka Sakae, Hidenao Fukuyama, Yoshio Hirota, Masaki Nagai, LRRK2 Gly2385Arg polymorphism, cigarette smoking, and risk of sporadic Parkinson's disease: A case–control study in Japan, Journal of the Neurological Sciences, 2010, 297, 1-2, 15

    CrossRef

  20. 20
    E.K. Tan, R. Peng, Y.R. Wu, R.M. Wu, Y.H. Wu-Chou, L.C. Tan, X.K. An, C.M. Chen, S. Fook-Chong, C.S. Lu, LRRK2 G2385R modulates age at onset in Parkinson's disease: A multi-center pooled analysis, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2009, 150B, 7
  21. 21
    Coro Paisán-Ruiz, LRRK2 gene variation and its contribution to Parkinson disease, Human Mutation, 2009, 30, 8
  22. 22
    Cyrus P. Zabetian, Mitsutoshi Yamamoto, Alexis N. Lopez, Hiroshi Ujike, Ignacio F. Mata, Yuishin Izumi, Ryuji Kaji, Hirofumi Maruyama, Hiroyuki Morino, Masaya Oda, Carolyn M. Hutter, Karen L. Edwards, Gerard D. Schellenberg, Debby W. Tsuang, Dora Yearout, Eric B. Larson, Hideshi Kawakami, LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease, Movement Disorders, 2009, 24, 7
  23. 23
    Lihua Yu, Fayun Hu, Xiaoyi Zou, Yi Jiang, Yan Liu, Xianghua He, Jing Xi, Ling Liu, Zhuolin Liu, Li He, Yanming Xu, LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China, Brain Research, 2009, 1296, 113

    CrossRef

  24. 24
    Zijuan Zhang, Jean-Marc Burgunder, Xingkai An, Yan Wu, Wenjun Chen, Jinhong Zhang, Yingcheng Wang, Yanming Xu, Yingru Gou, Guanggu Yuan, Xueye Mao, Rong Peng, LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China, Movement Disorders, 2009, 24, 13
  25. 25
    S. Lesage, A. Brice, Parkinson's disease: from monogenic forms to genetic susceptibility factors, Human Molecular Genetics, 2009, 18, R1, R48

    CrossRef

  26. 26
    Owen A. Ross, Yih-Ru Wu, Mei-Ching Lee, Manabu Funayama, Meng-Ling Chen, Alexandra I. Soto, Ignacio F. Mata, Guey-Jen Lee-Chen, Chiung Mei Chen, Michelle Tang, Yi Zhao, Nobutaka Hattori, Matthew J. Farrer, Eng-King Tan, Ruey-Meei Wu, Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease, Annals of Neurology, 2008, 64, 1
  27. 27
    Chin-Song Lu, Yah-Huei Wu-Chou, Marina Doeselaar, Erik J. Simons, Hsiu-Chen Chang, Guido J. Breedveld, Alessio Fonzo, Rou-Shayn Chen, Yi-Hsin Weng, Szu-Chia Lai, Ben A. Oostra, Vincenzo Bonifati, The LRRK2 Arg1628Pro variant is a risk factor for Parkinson’s disease in the Chinese population, Neurogenetics, 2008, 9, 4, 271

    CrossRef